Gene · 1290
Papers2,039
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,039
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel variations in the PLOD1, COL1A1, COL5A2 and COL4A1 genes related to keratoconus. | Front Genet | 2025 | 40201566 | PubTator, text mining | PubMed |
| Integrative bioinformatics analysis of high-throughput sequencing and in vitro functional analysis leads to uncovering key hub genes in esophageal squamous cell carcinoma. | Hereditas | 2025 | 40087784 | PubTator, text mining | PubMed |
| Genetic Overlap of Thoracic Aortic Aneurysms and Intracranial Aneurysms. | Genes (Basel) | 2025 | 40004483 | PubTator, text mining | PubMed |
| Construction and verification of a prognostic model for bladder cancer based on disulfidptosis-related angiogenesis genes. | PeerJ | 2025 | 39995998 | PubTator, text mining | PubMed |
| Comprehensive bioinformatic analysis reveals prognostic significance and functional insights of candidate gene expression in colorectal cancer. | Sci Rep | 2025 | 39955350 | PubTator, text mining | PubMed |
| Suppressing the progression of bladder cancer using cyclovirobuxine D based on network pharmacology and bioinformatics approaches. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39797986 | PubTator, text mining | PubMed |
| Integrative analyses of mendelian randomization and bioinformatics reveal casual relationship and genetic links between COVID-19 and knee osteoarthritis. | BMC Med Genomics | 2025 | 39748395 | PubTator, text mining | PubMed |
| CAF-secreted COL5A2 activates the PI3K/AKT pathway to mediate erlotinib resistance in head and neck squamous cell carcinoma. | Oral Dis | 2025 | 39286945 | PubTator, text mining | PubMed |
| Classical Ehlers-Danlos syndrome with cranio-cervical instability in an infant due to a novel COL5A1 gene mutation. | BMJ Case Rep | 2024 | 39950632 | PubTator, text mining | PubMed |
| Identification and validation of the diagnostic biomarker MFAP5 for CAVD with type 2 diabetes by bioinformatics analysis. | Front Immunol | 2024 | 39749331 | PubTator, text mining | PubMed |
| Transcriptomics-informed pharmacology identifies epigenetic and cell cycle regulators that enhance AAV production. | Mol Ther Methods Clin Dev | 2024 | 39687728 | PubTator, text mining | PubMed |
| A novel hypoxia- and lactate metabolism-related prognostic signature to characterize the immune landscape and predict immunotherapy response in osteosarcoma. | Front Immunol | 2024 | 39569192 | PubTator, text mining | PubMed |
| Downregulation of Genes for Skeletal Muscle Extracellular Matrix Components by Cisplatin. | Biol Pharm Bull | 2024 | 39522978 | PubTator, text mining | PubMed |
| Identification of hub genes through integrated single-cell and microarray transcriptome analysis in osteoarthritic meniscus. | J Orthop Surg Res | 2024 | 39438957 | PubTator, text mining | PubMed |
| Development and experimental verification of novel angiogenesis related prognostic model and immune infiltration characterization in osteosarcoma. | Discov Oncol | 2024 | 39237807 | PubTator, text mining | PubMed |
| Novel COL5A1 variants and associated disease phenotypes in dogs with classical Ehlers-Danlos syndrome. | J Vet Intern Med | 2024 | 39175162 | PubTator, text mining | PubMed |
| Osteoporosis in Relation to a Bone-Related Aging Biomarker Derived from the Urinary Proteomic Profile: A Population Study. | Aging Dis | 2024 | 39122459 | PubTator, text mining | PubMed |
| Anti-photoaging effect and the mechanism of Coreopsis tinctoria okanin against UVB-induced skin damage in mice. | Int Immunopharmacol | 2024 | 39024749 | PubTator, text mining | PubMed |
| A novel cancer-associated fibroblasts risk score model predict survival and immunotherapy in lung adenocarcinoma. | Mol Genet Genomics | 2024 | 39017768 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals special basal cells and fibroblasts in idiopathic pulmonary fibrosis. | Sci Rep | 2024 | 38982264 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1290/papers?page=5